We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gateley (holdings) Plc | LSE:GTLY | London | Ordinary Share | GB00BXB07J71 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -0.83% | 120.00 | 120.00 | 121.00 | 121.00 | 120.50 | 120.50 | 820,569 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Legal Services | 162.73M | 12.24M | 0.0930 | 12.96 | 158.63M |
TIDMGTLY
RNS Number : 6378B
Gateley (Holdings) PLC
04 October 2022
4 October 2022
Gateley (Holdings) Plc
("Gateley" or the "Group")
(AIM:GTLY)
Acquisition of Symbiosis IP Limited,
Issue of Equity and Total Voting Rights
Gateley, the legal and professional services group , is pleased to announce the acquisition (the "Acquisition") of Symbiosis IP Limited ("Symbiosis") for a maximum consideration of circa GBP2.5 million.
Founded in 2008 by Directors, Julie Myint and Rob Docherty, Symbiosis is a chartered patent attorney firm specialising in IP services for the life sciences industry. Symbiosis is the second patent attorney business Gateley has acquired onto its Business Services Platform following the acquisition of Adamson Jones in January 2022. For the year ended 31 March 2022, Symbiosis delivered revenue of GBP1.8 million, with corporatised profit before tax of GBP0.3 million.
Acquisition rationale
Alongside Adamson Jones, the Acquisition of Symbiosis further enhances the development of complementary business services with an IP and brands focus. The Group aims to build an industry relevant patent and trademark attorney offering via a mix of acquisitive and organic growth, and by adding new patent specialisms and geographical areas.
Terms of the Acquisition
Under the terms of the Acquisition agreement, the Group will pay consideration of approximately GBP2.5 million (the "Consideration") subject to a completion accounts adjustment. The Consideration will be satisfied as to approximately GBP1.5 million in cash and GBP1.0 million by the allotment and issue of new ordinary shares of GBP0.10 each in Gateley ("Consideration Shares"). Any adjustment following agreement of the completion accounts will be deductible from the cash element of the Consideration. GBP1 million of the cash consideration is being funded from the Group's revolving credit facility with the balance of GBP0.5 million from existing cash resources.
Issue of the Consideration Shares and Total Voting Rights
Further to the Acquisition, 523,012 Consideration Shares are to be issued. Application will be made to the London Stock Exchange for the 523,012 Consideration Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will take place at 8:00 a.m. on Friday 7 October 2022.
The Consideration Shares will rank pari passu in all respects with the existing ordinary shares of GBP0.10 each of Gateley ("Ordinary Shares"), including the right to receive all dividends declared, made or paid after completion.
Following Admission, Gateley's total issued share capital will comprise 125,141,617 Ordinary Shares. This number may be used by shareholders in Gateley as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Gateley under the FCA's Disclosure Guidance and Transparency Rules.
Commenting on the Acquisition, Rod Waldie, Chief Executive Officer of Gateley, said:
"I am delighted to welcome Symbiosis to the Group. T his strategic acquisition will extend the reach of our offering in IP, patents and trademark work across our consultancy and legal services teams who operate in this field. The Acquisition of Symbiosis forms part of an acquisitive and organic growth plan that builds on the expertise we have in the intangible assets market and where we believe there is potential for further development."
Enquiries:
Gateley (Holdings) Plc Neil Smith, Finance Director Tel: +44 (0) 121 234 0196 Nick Smith, Acquisitions Director and Tel: +44 (0) 20 7653 Head of Investor Relations 1665 Cara Zachariou, Head of Corporate Communications Tel: +44 (0) 121 234 0074 Mob: +44 (0) 7703 684 946 Liberum - Nominated Adviser and Broker Richard Lindley/Ben Cryer/Cara Murphy Tel: +44 (0) 20 3100 2000 Belvedere Communications Limited - Financial PR Cat Valentine Mob: +44 (0) 7715 769 078 Keeley Clarke Mob: +44 (0) 7967 816 525 Llew Angus Mob: +44 (0) 7407 023 147 gateleypr@belvederepr.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACQUPGWAUUPPGBW
(END) Dow Jones Newswires
October 04, 2022 02:00 ET (06:00 GMT)
1 Year Gateley (holdings) Chart |
1 Month Gateley (holdings) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions